XTLB (XTLB) Stock Price & Analysis
XTLB (XTLB) rose 0.00% to USD 2.94 as of July 25, 2026 at 06:15 UTC, according to Nexqual real-time market data.
XTLB last closed at USD 2.94; the session ranged USD 2.77–2.94 on volume of 1,225 shares. Market capitalization is —, with a 52-week range of USD 2.01–10.28 (NCM). Source: Nexqual, July 25, 2026 at 06:15 UTC.
Key Statistics (as of July 25, 2026 at 06:15 UTC)
| Price | USD 2.94 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 2.94 |
| Open | USD 2.94 |
| Day Range | USD 2.77 – 2.94 |
| 52-Week Range | USD 2.01 – 10.28 |
| Volume | 1,225 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (XTLB)
Nexqual's technical model rates XTLB "STRONG BUY" based on 5 bullish and 0 bearish signals across 125 daily candles, as of July 25, 2026 at 06:15 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 61.9 (neutral) |
| vs SMA50 | Above (USD 2.6) |
| MACD | 0.09 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BNTC | Benitec Biopharma Inc. | USD 11.47 | ▲ 0.26% |
| XBIO | Xenetic Biosciences, Inc. | USD 2.64 | ▼ 1.12% |
| KZIA | Kazia Therapeutics Limited | USD 12.26 | ▼ 16.03% |
| TENX | Tenax Therapeutics, Inc. | USD 14.53 | ▼ 1.76% |
| XELB | Xcel Brands, Inc | USD 1.23 | ▼ 9.56% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:15 UTC. This page is informational and not investment advice.